Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6 - Yang, J C; Sequist, L V; Geater, S L (Lancet Oncol, 2015)
, et al.